Oh, Jason Z <br/><br/>
The capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Oct 2010 
 - 4602-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.1001892  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cross-Priming--immunology<br/>Dendritic Cells--immunology<br/>Membrane Glycoproteins--agonists<br/>Mice<br/>Mice, Inbred C57BL<br/>Ovalbumin--immunology<br/>Toll-Like Receptor 7--agonists<br/>Vaccines, Conjugate--immunology